Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Preclinical and clinical studies indicate safety and efficacy of SB-209509/VML-251 for migraine

June 19, 1997

Preclinical studies reported for rizatriptan

June 19, 1997

Almotriptan: a novel antimigraine agent from Almirall

June 19, 1997

Preclinical profile of novel migraine abortive from BMS

June 19, 1997

Targets for antimigraine therapy: antiepileptic drugs in the treatment of migraine

June 19, 1997

Novel CCK-B antagonist with anxiolytic activity from Rotta

June 18, 1997

High-dose riboflavin for migraine prophylaxis

June 18, 1997

Targets for antimigraine therapy: SSRIs in the prevention of migraine

June 18, 1997

Targets for antimigraine therapy: NOS inhibitors as new therapeutic approach

June 18, 1997

Targets for antimigraine therapy: NK1 blockade not an effective antimigraine strategy

June 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...